These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors. Srinivasan VM; Lang FF; Chen SR; Chen MM; Gumin J; Johnson J; Burkhardt JK; Kan P J Neurointerv Surg; 2020 Feb; 12(2):197-203. PubMed ID: 31676690 [TBL] [Abstract][Full Text] [Related]
9. Endovascular superselective treatment of brain tumors: a new endovascular era? A quick review. Peschillo S; Miscusi M; Missori P J Neurointerv Surg; 2015 Mar; 7(3):222-4. PubMed ID: 24510377 [TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study. Gururangan S; Chi SN; Young Poussaint T; Onar-Thomas A; Gilbertson RJ; Vajapeyam S; Friedman HS; Packer RJ; Rood BN; Boyett JM; Kun LE J Clin Oncol; 2010 Jun; 28(18):3069-75. PubMed ID: 20479404 [TBL] [Abstract][Full Text] [Related]
11. Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Shin BJ; Burkhardt JK; Riina HA; Boockvar JA Neurosurg Clin N Am; 2012 Apr; 23(2):323-9, ix-x. PubMed ID: 22440875 [TBL] [Abstract][Full Text] [Related]
12. [Superselective intra-arterial administration of bevacizumab with blood-brain barrier disruption in patients with recurrent malignant gliomas: case report and literature review]. Kaprin AD; Zaitsev AM; Rerberg AG; Fedenko AA; Datsenko PV; Kirsanova ON Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(5):64-70. PubMed ID: 34714005 [TBL] [Abstract][Full Text] [Related]
13. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study. Chakraborty S; Filippi CG; Wong T; Ray A; Fralin S; Tsiouris AJ; Praminick B; Demopoulos A; McCrea HJ; Bodhinayake I; Ortiz R; Langer DJ; Boockvar JA J Neurooncol; 2016 Jul; 128(3):405-15. PubMed ID: 26945581 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features. Moriya S; Ohba S; Adachi K; Nishiyama Y; Hayashi T; Nagahisa S; Kaito T; Nakae S; Hirose Y J Clin Neurosci; 2018 Jan; 47():228-233. PubMed ID: 29050897 [TBL] [Abstract][Full Text] [Related]
15. Superselective cerebral arterial infusion of BCNU in high-grade glioma: the radiologist's point of view. Fontaine S; Théron J; Melanson D; Villemure JG; Emrich J; Raymond J; Ethier R Can Assoc Radiol J; 1988 Sep; 39(3):178-81. PubMed ID: 2971050 [TBL] [Abstract][Full Text] [Related]
16. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report. Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124 [TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Norden AD; Young GS; Setayesh K; Muzikansky A; Klufas R; Ross GL; Ciampa AS; Ebbeling LG; Levy B; Drappatz J; Kesari S; Wen PY Neurology; 2008 Mar; 70(10):779-87. PubMed ID: 18316689 [TBL] [Abstract][Full Text] [Related]
18. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Nakagawa H; Fujita T; Kubo S; Tsuruzono K; Yamada M; Tokiyoshi K; Miyawaki Y; Kanayama T; Kadota T; Hayakawa T Surg Neurol; 1994 Jan; 41(1):19-27. PubMed ID: 8310382 [TBL] [Abstract][Full Text] [Related]
19. Superselective intra-arterial cerebral infusion to improve brain tumor drug delivery. Rechberger JS; Hayes CA; Thiele F; Power EA; Daniels DJ Ther Deliv; 2022 Jan; 13(1):1-4. PubMed ID: 34726471 [TBL] [Abstract][Full Text] [Related]
20. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report. Pollack IF; Jakacki RI; Blaney SM; Hancock ML; Kieran MW; Phillips P; Kun LE; Friedman H; Packer R; Banerjee A; Geyer JR; Goldman S; Poussaint TY; Krasin MJ; Wang Y; Hayes M; Murgo A; Weiner S; Boyett JM Neuro Oncol; 2007 Apr; 9(2):145-60. PubMed ID: 17293590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]